SANTEN PHARMACEUTICAL CO.,LTD.JP:4536Income statement

Market cap
¥600.3B
P/E ratio
17.1x
2012/032013/032014/032015/032016/032017/032018/032019/032020/032021/032022/032023/032024/032025/03
Revenue114,416119,066148,663161,881195,291199,096224,942234,026241,555249,605266,257279,037301,965300,004
Revenue growth (%)-
Cost of revenue---56,37372,82974,96670,20575,22278,47681,39187,40287,41592,06296,587
Gross profit---105,458122,463124,130101,667100,986104,134104,721103,425109,174103,17691,513
Gross margin (%)---
Operating margin (%)---
Operating expenses ---55,43065,08564,28470,36968,13769,70081,10882,03784,37675,16468,105
Operating income ---33,18830,71331,31131,29845,09833,53512,91735,886-3,09038,54146,880
Income before tax 27,78025,60230,36135,86379,47031,82239,26143,11732,09112,41835,616-5,79929,87447,481
Pretax margin (%)24.321.520.422.240.71617.518.413.3513.4-2.19.915.8
Provision for income taxes---11,22123,4015,6177,5649,94610,0145,6637,7839,5017,1237,333
Effective tax rate (%)---
Net income 17,16016,52019,71824,03253,37323,06135,24731,95423,6186,83027,218-14,94826,64236,256
Net income margin (%)
Earnings per share196.96195.8147.7858.18128.9956.286.7378.6759.1617.0968.07-38.672.59103.98
Diluted EPS196.76195.5141.3354.41123.7960.762.3668.7668.4654.3343.53-38.650.7450.89
Dividend payout ratio (%)--------
Dividend per share--------272832323336
EBITDA------
EBITDA margin (%)------